SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study

NCT02840708 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Alveolar Proteinosis, Autoimmune

Interventions

DRUG: Sargramostim

Sponsor

Niigata University Medical & Dental Hospital